Search - tctmd.com

Displaying 181 - 200 of 206

Sort: Relevancy | Date

News Daily News

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Jason Kahn

October 19, 2012

News Daily News

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

October 12, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Daily News

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

July 05, 2012

News Daily News

Registry Finds Overall Decrease in Post-PCI Bleeding but Not in STEMI

Caitlin E. Cox

June 01, 2012

News Daily News

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

May 09, 2012

Presentation TCT Mediterranean 2012

Anticoagulation in ACS: Role of Bivalirudin

Presenter: Gregg W. Stone

May 04, 2012

News Conference News ACC 2012

INFUSE-AMI: Bolus Abciximab Works, Thrombus Aspiration Doesn’t for Large STEMI

Jason Kahn

March 25, 2012

News Daily News

HORIZONS-AMI: Radial Access PCI Reduces Bleeding, MACE in STEMI

March 07, 2012

News Conference News Cell Therapy 2012

Expedited Cell Therapy After STEMI Shows Promise

January 29, 2012

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Daily News

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

L.A. McKeown

November 01, 2011

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Daily News

Delayed Stenting Optimizes Microvascular Perfusion in STEMI Patients

October 26, 2011

News Daily News

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Yael L. Maxwell

October 13, 2011

News Daily News

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

L.A. McKeown

September 13, 2011

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

News Daily News

RESOLUTE All Comers Looks at Simple, Complex Cases in Comparing ZES, EES

L.A. McKeown

June 10, 2011

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

L.A. McKeown

June 03, 2011

Advertisement

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

Registry Finds Overall Decrease in Post-PCI Bleeding but Not in STEMI

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

Anticoagulation in ACS: Role of Bivalirudin

INFUSE-AMI: Bolus Abciximab Works, Thrombus Aspiration Doesn’t for Large STEMI

HORIZONS-AMI: Radial Access PCI Reduces Bleeding, MACE in STEMI

Expedited Cell Therapy After STEMI Shows Promise

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

Delayed Stenting Optimizes Microvascular Perfusion in STEMI Patients

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

Novel Anticoagulants Showing Benefits in A-fib Subgroups

RESOLUTE All Comers Looks at Simple, Complex Cases in Comparing ZES, EES

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content